GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
7YGG | Q08722 | Crystal structure of human CD47 in complex with engineered SIRPa.D1(N80A) | |
7YQT | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) | |
7YQU | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | |
7YQV | P0DTC2 | pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) | |
7YQW | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | |
7YQX | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) | |
7YQX | 7YQX | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) | |
7YQY | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) | |
7YQY | 7YQY | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) | |
7YQZ | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) | |
7YQZ | 7YQZ | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) | |
7YR0 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) | |
7YR0 | 7YR0 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) | |
7YR1 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 | |
7YR1 | 7YR1 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 | |
7YR2 | Q9BYF1 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) | |
7YR2 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) | |
7YR3 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) | |
7YR3 | Q9BYF1 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) | |
8B80 | W8QF82 | The structure of Gan1D W433A in complex with galactose-6P | |
8B81 | W8QF82 | The structure of Gan1D W433A in complex with cellobiose-6-phosphate | |
8D8Q | P0DTC2 | SARS-CoV-2 Spike RBD in complex with DMAbs 2130 and 2196 | |
8D8Q | 8D8Q | SARS-CoV-2 Spike RBD in complex with DMAbs 2130 and 2196 | |
8D8R | P0DTC2 | SARS-CoV-2 Spike RBD in complex with DMAb 2196 | |
8D8R | 8D8R | SARS-CoV-2 Spike RBD in complex with DMAb 2196 | |
8GVM | P00396 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P68530 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00415 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00423 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00426 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00428 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P07471 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00429 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P04038 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P07470 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P13183 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P00430 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8GVM | P10175 | The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days | |
8H10 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-2 Conformation | |
8H13 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Closed Conformation | |
8H14 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x3 Disulfide (D414C and V969C), Locked-1 Conformation | |
7WTF | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab XGv051 | |
7WTF | 7WTF | SARS-CoV-2 Omicron variant spike in complex with Fab XGv051 | |
7WTK | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab XGv286 | |
7WTK | 7WTK | SARS-CoV-2 Omicron variant spike in complex with Fab XGv286 | |
7X2M | 7X2M | Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD | |
7X2M | P0DTC2 | Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD | |
7ZHV | A2CIL3 | Leishmania donovani Glucose 6-Phosphate Dehydrogenase complexed with Glucose 6-Phosphate | |
7ZHW | A2CIL3 | Leishmania donovani Glucose 6-Phosphate Dehydrogenase complexed with NADP(H) and Glucose 6-Phosphate | |
7ZHZ | A2CIL3 | Leishmania donovani Glucose 6-Phosphate Dehydrogenase mutant C138S complexed with G6P and NADP(H) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024